Sponsored by Wachovia

IBTimes Logo

Watson to sell iron treatment through end of year

Watson Pharmaceuticals Inc will continue to sell the Ferrlecit iron deficiency treatment in the United States for the rest of the year following an arbitrator's ruling, the company said on Monday, giving Watson a victory for its closely watched product.